Scilex Holding (SCLX) Operating Leases (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Operating Leases of $12.7 million for Q1 2026, up 855.99% year-over-year from $1.3 million in Q1 2025, and down 3.54% quarter-over-quarter from $13.2 million in Q4 2025.
Scilex Holding (SCLX) Operating Leases (2021 - 2026) Analysis & Trends
Scilex Holding's Operating Leases history runs 6 years deep, the most recent figure standing at $12.7 million for Q1 2026.
- In Q1 2026, Operating Leases rose 855.99% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (up 855.99% YoY), while the FY2025 annual figure was $13.2 million, up 763.49% from the prior year.
- Operating Leases for Q1 2026 stood at $12.7 million, down from $13.2 million in the prior quarter.
- The five-year high for Operating Leases was $13.2 million in Q4 2025, with the low at $461000.0 in Q1 2023.
- The 5-year median for Operating Leases is $1.8 million (2024), against an average of $3.2 million.
- The sharpest annual moves came in 2025 and 2026: Operating Leases plunged 46.44% in 2025, then surged 855.99% in 2026.
- Scilex Holding's Operating Leases stood at $665000.0 in 2022, then soared by 236.39% to $2.2 million in 2023, then sank by 31.92% to $1.5 million in 2024, then soared by 763.49% to $13.2 million in 2025, then slipped by 3.54% to $12.7 million in 2026.
- Business Quant data shows SCLX's Operating Leases at $12.7 million in Q1 2026, $13.2 million in Q4 2025, and $918000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.69 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 665,000.00 |
| Dec 31, 2021 | 1.15 Mn |